STOCK TITAN

OPKO Health to Report Second Quarter 2025 Financial Results on July 31

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences earnings

OPKO Health (NASDAQ:OPK) has scheduled its Second Quarter 2025 financial results announcement for July 31, 2025, after U.S. market close. The company will host a conference call and webcast at 4:30 p.m. Eastern time to discuss operating and financial results for the three and six months ended June 30, 2025.

Participants can pre-register for the call through a provided link, or join by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A replay will be available until August 7, 2025, accessible via phone or webcast.

OPKO Health (NASDAQ:OPK) ha programmato l'annuncio dei risultati finanziari del Secondo Trimestre 2025 per il 31 luglio 2025, dopo la chiusura del mercato statunitense. La società terrà una conference call e una trasmissione web alle 16:30 ora orientale per discutere i risultati operativi e finanziari relativi ai tre e sei mesi terminati il 30 giugno 2025.

I partecipanti possono preregistrarsi per la chiamata tramite un link fornito, oppure partecipare chiamando il numero 833-630-0584 (USA) o 412-317-1815 (Internazionale). Una registrazione sarà disponibile fino al 7 agosto 2025, accessibile via telefono o webcast.

OPKO Health (NASDAQ:OPK) ha programado el anuncio de sus resultados financieros del Segundo Trimestre de 2025 para el 31 de julio de 2025, después del cierre del mercado estadounidense. La compañía realizará una llamada conferencia y una transmisión web a las 4:30 p.m. hora del este para discutir los resultados operativos y financieros correspondientes a los tres y seis meses terminados el 30 de junio de 2025.

Los participantes pueden pre-registrarse para la llamada mediante un enlace proporcionado, o unirse llamando al 833-630-0584 (EE.UU.) o al 412-317-1815 (Internacional). Una repetición estará disponible hasta el 7 de agosto de 2025, accesible por teléfono o webcast.

OPKO Health (NASDAQ:OPK)2025년 2분기 재무 실적 발표를 2025년 7월 31일 미국 시장 마감 후에 예정했습니다. 회사는 동부 표준시 오후 4시 30분에 컨퍼런스 콜과 웹캐스트를 개최하여 2025년 6월 30일 종료된 3개월 및 6개월간의 운영 및 재무 실적을 논의할 예정입니다.

참석자들은 제공된 링크를 통해 사전 등록하거나 833-630-0584 (미국) 또는 412-317-1815 (국제)로 전화해 참여할 수 있습니다. 녹음된 재방송은 2025년 8월 7일까지 전화 또는 웹캐스트를 통해 이용 가능합니다.

OPKO Health (NASDAQ:OPK) a programmé l'annonce de ses résultats financiers du deuxième trimestre 2025 pour le 31 juillet 2025, après la clôture du marché américain. La société organisera une conférence téléphonique et une diffusion en webcast à 16h30 heure de l'Est pour discuter des résultats opérationnels et financiers des trois et six mois clos le 30 juin 2025.

Les participants peuvent se préinscrire à l'appel via un lien fourni, ou rejoindre en composant le 833-630-0584 (États-Unis) ou le 412-317-1815 (International). Une rediffusion sera disponible jusqu'au 7 août 2025, accessible par téléphone ou webcast.

OPKO Health (NASDAQ:OPK) hat die Bekanntgabe der Finanzergebnisse für das zweite Quartal 2025 für den 31. Juli 2025 nach Börsenschluss in den USA geplant. Das Unternehmen wird um 16:30 Uhr Eastern Time eine Telefonkonferenz und einen Webcast veranstalten, um die operativen und finanziellen Ergebnisse für die drei und sechs Monate bis zum 30. Juni 2025 zu besprechen.

Teilnehmer können sich über einen bereitgestellten Link vorregistrieren oder per Telefon unter 833-630-0584 (USA) oder 412-317-1815 (international) teilnehmen. Eine Aufzeichnung wird bis zum 7. August 2025 verfügbar sein und ist per Telefon oder Webcast zugänglich.

Positive
  • None.
Negative
  • None.

MIAMI, July 24, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three and six months ended June 30, 2025 after the close of the U.S. financial markets on Thursday, July 31, 2025. OPKO’s senior management will provide a business update and discuss results as well as financial guidance during a conference call and live audio webcast on July 31 beginning at 4:30 p.m. Eastern time.

CONFERENCE CALL & WEBCAST INFORMATION

OPKO encourages participants to pre-register for the conference call using this link. Callers who pre-register will receive a unique PIN to gain immediate access to the call and bypass the live operator. Participants may register at any time, including up to and after the call start time. Those unable to pre-register may participate by dialing 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast of the call can also be accessed at OPKO’s Investor Relations page and here.

A telephone replay will be available until August 7, 2025, by dialing 877-344-7529 (U.S.) or 412-317-0088 (International) and providing the passcode 3096711. A webcast replay will be available beginning approximately one hour after the completion of the live conference call here.

About OPKO Health

OPKO is a multinational biopharmaceutical and diagnostics company that seeks to establish industry-leading positions in large, rapidly growing markets by leveraging its discovery, development, and commercialization expertise and novel and proprietary technologies. For more information, visit www.opko.com.

Contacts:

Alliance Advisors IR
Yvonne Briggs, 310-691-7100
ybriggs@allianceadvisors.com
or
Bruce Voss, 310-691-7100
bvoss@allianceadvisors.com


FAQ

When will OPKO Health (OPK) release Q2 2025 earnings?

OPKO Health will release Q2 2025 earnings on Thursday, July 31, 2025 after U.S. market close.

What time is OPKO Health's Q2 2025 earnings call?

OPKO Health's Q2 2025 earnings conference call and webcast will begin at 4:30 p.m. Eastern time on July 31, 2025.

How can I join OPKO Health's Q2 2025 earnings call?

You can pre-register through the company's link, or dial 833-630-0584 (U.S.) or 412-317-1815 (International). A webcast is also available on OPKO's Investor Relations page.

How long will OPKO Health's Q2 2025 earnings call replay be available?

The earnings call replay will be available until August 7, 2025, accessible by phone using passcode 3096711 or via webcast on OPKO's website.
Opko Health

NASDAQ:OPK

OPK Rankings

OPK Latest News

OPK Latest SEC Filings

OPK Stock Data

1.07B
421.79M
59.26%
29.91%
13.32%
Diagnostics & Research
Pharmaceutical Preparations
Link
United States
MIAMI